首页 > 最新文献

Research in Social & Administrative Pharmacy最新文献

英文 中文
Professional autonomy in pharmacists: Independence within interdependence 药师的职业自主:相互依存中的独立。
IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-13 DOI: 10.1016/j.sapharm.2025.10.005
Paul Forsyth , Jessica Baker , Willa Saadat , Andrew Radley
As the duties of pharmacists evolve it can be difficult for many to foster and maintain professional autonomy within both new and core roles. However, it is important for us to understand what autonomy actually means. Autonomy is a common word in every-day use describing a philosophical concept concerning an agent's capacity for self-determination. Professional standards typically try to ensure the required level of individual professional autonomy necessary for pharmacists to deliver care in the best interests of patients. Professional autonomy is a key factor in achieving job satisfaction, meaningful work, and flourishing in a professional role, and when inhibited can lead to negative career experiences and outcomes. Autonomy can however be understood both in this individual sense, linked to liberty and independence, but also in a collective sense, linked to relationships and societal empowerment. This paper examines how pharmacists have understood these differing conceptual views of professional autonomy to date, describing the theoretical basis for each, and then sketching a series of short scenarios that illustrate how the professional autonomy of individual pharmacists can be heavily influenced by many interdependent factors, including relational factors, employment factors, professional factors, and societal factors. Finally, the paper considers the principles and skills needed for pharmacists to create a more stable professional autonomy, both individually and collectively.
随着药剂师职责的演变,对于许多人来说,在新的和核心的角色中培养和保持专业自主权是很困难的。然而,理解自治的真正含义对我们来说很重要。自治是一个日常使用的常见词汇,描述了一个关于主体自决能力的哲学概念。专业标准通常试图确保药剂师为患者提供最佳利益所必需的个人专业自主水平。职业自主是获得工作满意度、有意义的工作和在职业角色中蓬勃发展的关键因素,当被抑制时,可能会导致负面的职业经历和结果。然而,自治既可以从与自由和独立相关的个人意义上理解,也可以从与关系和社会赋权相关的集体意义上理解。本文考察了迄今为止药剂师如何理解这些不同的专业自主概念观点,描述了每种观点的理论基础,然后勾勒出一系列简短的场景,说明药师个人的专业自主如何受到许多相互依存的因素的严重影响,包括关系因素、就业因素、专业因素和社会因素。最后,本文考虑了药剂师创造更稳定的专业自主权所需的原则和技能,无论是个人还是集体。
{"title":"Professional autonomy in pharmacists: Independence within interdependence","authors":"Paul Forsyth ,&nbsp;Jessica Baker ,&nbsp;Willa Saadat ,&nbsp;Andrew Radley","doi":"10.1016/j.sapharm.2025.10.005","DOIUrl":"10.1016/j.sapharm.2025.10.005","url":null,"abstract":"<div><div>As the duties of pharmacists evolve it can be difficult for many to foster and maintain professional autonomy within both new and core roles. However, it is important for us to understand what autonomy actually means. Autonomy is a common word in every-day use describing a philosophical concept concerning an agent's capacity for self-determination. Professional standards typically try to ensure the required level of individual professional autonomy necessary for pharmacists to deliver care in the best interests of patients. Professional autonomy is a key factor in achieving job satisfaction, meaningful work, and flourishing in a professional role, and when inhibited can lead to negative career experiences and outcomes. Autonomy can however be understood both in this individual sense, linked to liberty and independence, but also in a collective sense, linked to relationships and societal empowerment. This paper examines how pharmacists have understood these differing conceptual views of professional autonomy to date, describing the theoretical basis for each, and then sketching a series of short scenarios that illustrate how the professional autonomy of individual pharmacists can be heavily influenced by many interdependent factors, including relational factors, employment factors, professional factors, and societal factors. Finally, the paper considers the principles and skills needed for pharmacists to create a more stable professional autonomy, both individually and collectively.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 1","pages":"Pages 178-183"},"PeriodicalIF":2.8,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enabling real-world community pharmacy research: A realist review of practice-based research networks (PBRNs) 实现现实世界社区药学研究:基于实践的研究网络(pbrn)的现实主义回顾。
IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-13 DOI: 10.1016/j.sapharm.2025.10.004
Louisa Handyside , Jacqui Cameron , Christopher Freeman

Background

Engaging pharmacists in research and bridging the research-practice divide is a persistent challenge. Practice-based research networks aim to support research engagement, overcome research barriers, and generate evidence to advance practice. However, the outcomes of existing networks remain unexplored. Thus, the objectives of this realist review are: 1) to develop and refine a realist program theory to explain how and why these networks support research engagement and knowledge translation, for whom and in what contexts and 2) to provide preliminary recommendations to optimise network outcomes.

Methods

An initial program theory was developed, followed by an iterative process of formal and complementary searching. Data was selected, appraised, extracted, organised, and synthesised using a realist approach to refine the program theory.

Results

The refined program theory consisted of 12 context-mechanism-outcome configurations that explain the two key drivers of network success: 1) mutual benefits for a diverse range of actively engaged researchers and pharmacists, and 2) sustainable resourcing and maintenance of strategic collaborative partnerships. Stakeholder recommendations are underpinned by the modifiable contexts and resources that underscore optimal network outcomes.

Conclusion

A realist program theory was developed to explain how research networks may be used to bridge the divide between research and community pharmacy practice. The theory explains the causal processes underpinning successful outcomes and informs preliminary recommendations for network development, implementation, and maintenance. The review provides a robust foundation to explain how networks can optimise community pharmacy research. Futher research is warranted to confirm their translational potential.
背景:从事研究和弥合研究与实践的鸿沟药剂师是一个持久的挑战。基于实践的研究网络旨在支持研究参与,克服研究障碍,并产生证据以推进实践。然而,现有网络的结果仍未得到探索。因此,本现实主义回顾的目标是:1)发展和完善现实主义计划理论,以解释这些网络如何以及为什么支持研究参与和知识翻译,为谁以及在什么背景下支持;2)提供初步建议以优化网络结果。方法:建立了一个初步的程序理论,然后进行了形式和互补搜索的迭代过程。数据的选择,评估,提取,组织和综合使用现实主义的方法来完善程序理论。结果:完善的项目理论由12个情境-机制-结果配置组成,这些配置解释了网络成功的两个关键驱动因素:1)各种积极参与的研究人员和药剂师的互利;2)战略合作伙伴关系的可持续资源和维护。利益相关者的建议以可修改的环境和资源为基础,强调最佳的网络结果。结论:现实主义计划理论的发展是为了解释研究网络如何被用来弥合研究和社区药房实践之间的鸿沟。该理论解释了支撑成功结果的因果过程,并为网络开发、实施和维护提供了初步建议。该综述为解释网络如何优化社区药学研究提供了坚实的基础。需要进一步的研究来证实它们的转化潜力。
{"title":"Enabling real-world community pharmacy research: A realist review of practice-based research networks (PBRNs)","authors":"Louisa Handyside ,&nbsp;Jacqui Cameron ,&nbsp;Christopher Freeman","doi":"10.1016/j.sapharm.2025.10.004","DOIUrl":"10.1016/j.sapharm.2025.10.004","url":null,"abstract":"<div><h3>Background</h3><div>Engaging pharmacists in research and bridging the research-practice divide is a persistent challenge. Practice-based research networks aim to support research engagement, overcome research barriers, and generate evidence to advance practice. However, the outcomes of existing networks remain unexplored. Thus, the objectives of this realist review are: 1) to develop and refine a realist program theory to explain how and why these networks support research engagement and knowledge translation, for whom and in what contexts and 2) to provide preliminary recommendations to optimise network outcomes.</div></div><div><h3>Methods</h3><div>An initial program theory was developed, followed by an iterative process of formal and complementary searching. Data was selected, appraised, extracted, organised, and synthesised using a realist approach to refine the program theory.</div></div><div><h3>Results</h3><div>The refined program theory consisted of 12 context-mechanism-outcome configurations that explain the two key drivers of network success: 1) mutual benefits for a diverse range of actively engaged researchers and pharmacists, and 2) sustainable resourcing and maintenance of strategic collaborative partnerships. Stakeholder recommendations are underpinned by the modifiable contexts and resources that underscore optimal network outcomes.</div></div><div><h3>Conclusion</h3><div>A realist program theory was developed to explain how research networks may be used to bridge the divide between research and community pharmacy practice. The theory explains the causal processes underpinning successful outcomes and informs preliminary recommendations for network development, implementation, and maintenance. The review provides a robust foundation to explain how networks can optimise community pharmacy research. Futher research is warranted to confirm their translational potential.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 209-221"},"PeriodicalIF":2.8,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145423454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacists on the frontline: Medication misuse and abuse during violent conflict in four MENA countries 一线药剂师:四个中东和北非国家暴力冲突期间药物误用和滥用。
IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-11 DOI: 10.1016/j.sapharm.2025.10.003
Mayyada Wazaify , Christina Steenkamp , Haya Yasin

Purpose

An important, yet under-researched, impact of violent conflict on public health is the susceptibility of populations in conflicts to drug abuse and misuse as increased stress, the easy availability of drugs, and the relaxation of taboos against drug use exacerbate the problem. This study explores the experiences of pharmacists regarding drug misuse and abuse in four conflict-affected MENA countries.

Methods

The study is part of a larger two-year (2021–2023) project investigating the impact of violent conflict in the MENA region on medicine abuse and misuse and the experiences of pharmacists in managing this challenge. This part used a quantitative approach using survey methodology with a sample of pharmacists in Syria, Libya, Yemen and Iraq.

Results

A total of 181 questionnaires were filled (65.7 % male, mean age = 29.9 years old. The majority of the pharmacists (n = 170, 93.9 %) reported that on average, 27.88 % of the pharmacy customers were suspected of misusing/abusing medications in the past 3 months. The most misused medicines were pregabalin and sedatives/hypnotics followed by opioids like tramadol, in addition to cough and cold and anti-allergy preparations. Almost one-third of respondents (31.49 %) refused to dispense drugs which they thought were intended to be used inappropriately. Sixty-five (35.9 %) said that they had been subjected to violence for the sake of obtaining medications, and 17 (9.8 %) reported being threatened five times or more in the past year.

Conclusion

Based on the results above, future interventions in conflict settings must address both supply-side governance and the broader psychosocial drivers of medication misuse/abuse to ensure that pharmacists are supported rather than exposed in their essential work.
目的:暴力冲突对公共健康的一个重要但尚未得到充分研究的影响是,冲突中的人口容易受到药物滥用和误用的影响,因为压力的增加、药物的容易获得以及对药物使用禁忌的放松加剧了这一问题。本研究探讨了四个受冲突影响的中东和北非国家的药剂师在药物滥用和滥用方面的经验。方法:该研究是一个为期两年(2021-2023)的大型项目的一部分,该项目旨在调查中东和北非地区暴力冲突对药物滥用和误用的影响以及药剂师应对这一挑战的经验。本部分采用定量方法,对叙利亚、利比亚、也门和伊拉克的药剂师进行抽样调查。结果:共收集问卷181份,男性占65.7%,平均年龄29.9岁。大部分受访药师(170名,93.9%)表示,在过去3个月内,平均有27.88%的受访药师曾怀疑误用/滥用药品。滥用最多的药物是普瑞巴林和镇静剂/催眠药,其次是曲马多等阿片类药物,此外还有止咳、感冒药和抗过敏制剂。几乎三分之一的受访者(31.49%)拒绝配发他们认为意图不当使用的药物。65人(35.9%)表示,他们曾因获取药物而遭受暴力,17人(9.8%)报告在过去一年中受到五次或更多次威胁。结论:基于上述结果,未来在冲突环境中的干预措施必须解决供应方治理和药物误用/滥用的更广泛的社会心理驱动因素,以确保药剂师得到支持,而不是暴露在他们的基本工作中。
{"title":"Pharmacists on the frontline: Medication misuse and abuse during violent conflict in four MENA countries","authors":"Mayyada Wazaify ,&nbsp;Christina Steenkamp ,&nbsp;Haya Yasin","doi":"10.1016/j.sapharm.2025.10.003","DOIUrl":"10.1016/j.sapharm.2025.10.003","url":null,"abstract":"<div><h3>Purpose</h3><div>An important, yet under-researched, impact of violent conflict on public health is the susceptibility of populations in conflicts to drug abuse and misuse as increased stress, the easy availability of drugs, and the relaxation of taboos against drug use exacerbate the problem. This study explores the experiences of pharmacists regarding drug misuse and abuse in four conflict-affected MENA countries.</div></div><div><h3>Methods</h3><div>The study is part of a larger two-year (2021–2023) project investigating the impact of violent conflict in the MENA region on medicine abuse and misuse and the experiences of pharmacists in managing this challenge. This part used a quantitative approach using survey methodology with a sample of pharmacists in Syria, Libya, Yemen and Iraq.</div></div><div><h3>Results</h3><div>A total of 181 questionnaires were filled (65.7 % male, mean age = 29.9 years old. The majority of the pharmacists (n = 170, 93.9 %) reported that on average, 27.88 % of the pharmacy customers were suspected of misusing/abusing medications in the past 3 months. The most misused medicines were pregabalin and sedatives/hypnotics followed by opioids like tramadol, in addition to cough and cold and anti-allergy preparations. Almost one-third of respondents (31.49 %) refused to dispense drugs which they thought were intended to be used inappropriately. Sixty-five (35.9 %) said that they had been subjected to violence for the sake of obtaining medications, and 17 (9.8 %) reported being threatened five times or more in the past year.</div></div><div><h3>Conclusion</h3><div>Based on the results above, future interventions in conflict settings must address both supply-side governance and the broader psychosocial drivers of medication misuse/abuse to ensure that pharmacists are supported rather than exposed in their essential work.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 283-291"},"PeriodicalIF":2.8,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of pharmacist-led medication reconciliation and usual care on detecting and resolving discrepancies in major orthopaedic surgeries: A quasi-experimental study 药师主导的药物调解与常规护理在重大骨科手术中发现和解决差异的比较:一项准实验研究。
IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-10 DOI: 10.1016/j.sapharm.2025.10.001
Karen R. Palermo , Jesús Cotrina Luque , Natália Marto , Miriam Capoulas , Cláudia Santos , Isabel V. Figueiredo , Margarida Castel-Branco

Background

Medication reconciliation can reduce errors, particularly among elderly and polymedicated patients. The inclusion of pharmacists obtaining the best possible medication history can further improve the identification and resolution of discrepancies.

Aim

To compare a structured pharmacist-led medication reconciliation program with usual care on detecting and resolving discrepancies during hospital admission for major orthopaedic surgeries.

Methods

Quasi-experimental study, conducted in a Portuguese tertiary hospital, involving adult patients undergoing major orthopaedic surgery and taking chronic medication. In Phase One (usual care), reconciliation lacked standardization; pharmacists performed it alongside other tasks, relying solely on medical records and reported unintentional discrepancies electronically to prescribers. In Phase Two (pharmacist-led medication reconciliation), a designated pharmacist obtained the best possible medication history, identified discrepancies and communicated them directly to clinical pharmacologists. Validated high-risk criteria were used to assess clinical significance. Primary outcomes were identifying, classifying, and resolving unintentional discrepancies across both phases.

Results

The study included 182 patients (91 in each phase). In Phase One, 212 discrepancies were identified, 91 were unintentional, of which 30 had clinical significance. Ten pharmacist interventions were performed, with 50 % acceptance rate. In Phase Two, 339 discrepancies were identified, 129 were unintentional, of which 46 had clinical significance. A total of 104 pharmacist interventions were performed, with 73 % acceptance rate. Identification and resolution of unintentional discrepancies significantly increased (p < 0.001).

Conclusion

Pharmacist-led medication reconciliation, focusing on the best possible medication history collection and direct contact with physicians, significantly increased the identification and resolution of discrepancies, underlining its role in enhancing patient safety.
背景:药物和解可以减少错误,特别是在老年人和多药患者。纳入获得最佳用药史的药剂师可以进一步改善差异的识别和解决。目的:比较结构化药剂师主导的药物和解方案与常规护理在发现和解决重大骨科手术住院期间的差异方面的差异。方法:准实验研究,在葡萄牙某三级医院进行,涉及接受骨科大手术并长期服药的成年患者。在第一阶段(常规护理),和解缺乏标准化;药剂师在执行其他任务的同时,也只依靠医疗记录,并以电子方式向处方医生报告无意的差异。在第二阶段(药剂师主导的药物调解),指定的药剂师获得尽可能最好的用药史,识别差异并直接与临床药理学家沟通。采用经过验证的高危标准评估临床意义。主要结果是识别、分类和解决两个阶段的非故意差异。结果:研究纳入182例患者(每期91例)。在第一阶段,发现212个差异,91个是无意的,其中30个具有临床意义。进行10次药师干预,接受率为50%。在第二阶段,发现了339个差异,129个是无意的,其中46个具有临床意义。共实施药师干预104次,接受率为73%。结论:药师主导的药物调解,注重尽可能收集最佳用药史和与医生直接联系,显著增加了对差异的识别和解决,强调了其在提高患者安全方面的作用。
{"title":"Comparison of pharmacist-led medication reconciliation and usual care on detecting and resolving discrepancies in major orthopaedic surgeries: A quasi-experimental study","authors":"Karen R. Palermo ,&nbsp;Jesús Cotrina Luque ,&nbsp;Natália Marto ,&nbsp;Miriam Capoulas ,&nbsp;Cláudia Santos ,&nbsp;Isabel V. Figueiredo ,&nbsp;Margarida Castel-Branco","doi":"10.1016/j.sapharm.2025.10.001","DOIUrl":"10.1016/j.sapharm.2025.10.001","url":null,"abstract":"<div><h3>Background</h3><div>Medication reconciliation can reduce errors, particularly among elderly and polymedicated patients. The inclusion of pharmacists obtaining the best possible medication history can further improve the identification and resolution of discrepancies.</div></div><div><h3>Aim</h3><div>To compare a structured pharmacist-led medication reconciliation program with usual care on detecting and resolving discrepancies during hospital admission for major orthopaedic surgeries.</div></div><div><h3>Methods</h3><div>Quasi-experimental study, conducted in a Portuguese tertiary hospital, involving adult patients undergoing major orthopaedic surgery and taking chronic medication. In Phase One (usual care), reconciliation lacked standardization; pharmacists performed it alongside other tasks, relying solely on medical records and reported unintentional discrepancies electronically to prescribers. In Phase Two (pharmacist-led medication reconciliation), a designated pharmacist obtained the best possible medication history, identified discrepancies and communicated them directly to clinical pharmacologists. Validated high-risk criteria were used to assess clinical significance. Primary outcomes were identifying, classifying, and resolving unintentional discrepancies across both phases.</div></div><div><h3>Results</h3><div>The study included 182 patients (91 in each phase). In Phase One, 212 discrepancies were identified, 91 were unintentional, of which 30 had clinical significance. Ten pharmacist interventions were performed, with 50 % acceptance rate. In Phase Two, 339 discrepancies were identified, 129 were unintentional, of which 46 had clinical significance. A total of 104 pharmacist interventions were performed, with 73 % acceptance rate. Identification and resolution of unintentional discrepancies significantly increased (<em>p</em> &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>Pharmacist-led medication reconciliation, focusing on the best possible medication history collection and direct contact with physicians, significantly increased the identification and resolution of discrepancies, underlining its role in enhancing patient safety.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 263-271"},"PeriodicalIF":2.8,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A digital health-supported community pharmacy-based lifestyle intervention program for overweight or obese adults with prediabetes, the PRediabetes Intervention, Management and Evaluation (PRIME) Program: A cluster randomized controlled trial 糖尿病前期干预、管理和评估(PRIME)项目:一项针对超重或肥胖糖尿病前期成人的数字健康支持社区药房生活方式干预项目:一项随机对照试验。
IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-06 DOI: 10.1016/j.sapharm.2025.10.002
Kah Woon Teoh , Choon Ming Ng , Chun Wie Chong , Yi Ling Ng , J Simon Bell , Shaun Wen Huey Lee

Background

Evidence on the impact of using digital health tools to facilitate prediabetes management in community pharmacies is lacking. This study aimed to evaluate the effects of a digital health-supported and community pharmacy-based lifestyle intervention (PRIME) program on individuals with prediabetes in Malaysia.

Methods

A two-arm cluster randomised controlled trial was conducted in 16 community pharmacies from two states in Malaysia and included people with prediabetes that were overweight or obese. The intervention group received support of in-depth counselling from pharmacists, in-app prediabetes education modules, and peer support, while the usual care group received counselling based on pharmacists’ usual practice. The primary outcomes were the proportion of participants achieving ≥5 % weight loss and differential change in weight. All analyses were performed using intention to treat analyses with mixed effect modelling.

Findings

Ninety-one participants (intervention, n = 46; usual care n = 45) were recruited. At the end of study, participants in the intervention group were twice as likely compared to the usual care group to report a minimum 5 % weight loss (21 % intervention and 7.5 % usual care participants, odds ratio: 2.5, p = 0.266). Intervention group participants also reported a larger weight loss, with a mean difference of 1.26 kg (95 %CI -2.36 kg to −0.15 kg) between groups. These differences were more significant especially among those who were more engaged with PRIME.

Conclusion

The intervention showed greater weight loss than the usual care, but the proportion of individuals achieving clinically meaningful weight loss (≥5 %) was not significant. PRIME program can be an important and useful tool to improve risk factors among individuals with prediabetes especially in a low-resource setting. Further research is needed to determine the economic and long-term sustainability of such programs.
背景:缺乏关于使用数字健康工具促进社区药房糖尿病前期管理的影响的证据。本研究旨在评估马来西亚数字健康支持和基于社区药房的生活方式干预(PRIME)计划对前驱糖尿病患者的影响。方法:在马来西亚两个州的16个社区药房进行了一项双组随机对照试验,其中包括超重或肥胖的前驱糖尿病患者。干预组以药师深度咨询、app内糖尿病前期教育模块、同伴支持为支持,常规护理组以药师惯例为支持。主要结局是体重减轻≥5%的参与者比例和体重差异变化。所有分析均采用混合效应模型进行意向处理分析。结果:招募了91名参与者(干预组,n = 46;常规组,n = 45)。在研究结束时,干预组的参与者报告体重减轻至少5%的可能性是常规护理组的两倍(21%的干预和7.5%的常规护理参与者,优势比:2.5,p = 0.266)。干预组的参与者也报告了更大的体重减轻,组间平均差异为1.26 kg (95% CI -2.36 kg至-0.15 kg)。这些差异更显著,尤其是那些更参与PRIME的人。结论:与常规护理相比,干预显示出更大的体重减轻,但达到临床有意义的体重减轻(≥5%)的个体比例并不显著。PRIME计划可以成为改善糖尿病前期个体风险因素的重要而有用的工具,特别是在资源匮乏的环境中。需要进一步的研究来确定这些项目的经济和长期可持续性。
{"title":"A digital health-supported community pharmacy-based lifestyle intervention program for overweight or obese adults with prediabetes, the PRediabetes Intervention, Management and Evaluation (PRIME) Program: A cluster randomized controlled trial","authors":"Kah Woon Teoh ,&nbsp;Choon Ming Ng ,&nbsp;Chun Wie Chong ,&nbsp;Yi Ling Ng ,&nbsp;J Simon Bell ,&nbsp;Shaun Wen Huey Lee","doi":"10.1016/j.sapharm.2025.10.002","DOIUrl":"10.1016/j.sapharm.2025.10.002","url":null,"abstract":"<div><h3>Background</h3><div>Evidence on the impact of using digital health tools to facilitate prediabetes management in community pharmacies is lacking. This study aimed to evaluate the effects of a digital health-supported and community pharmacy-based lifestyle intervention (PRIME) program on individuals with prediabetes in Malaysia.</div></div><div><h3>Methods</h3><div>A two-arm cluster randomised controlled trial was conducted in 16 community pharmacies from two states in Malaysia and included people with prediabetes that were overweight or obese. The intervention group received support of in-depth counselling from pharmacists, in-app prediabetes education modules, and peer support, while the usual care group received counselling based on pharmacists’ usual practice. The primary outcomes were the proportion of participants achieving ≥5 % weight loss and differential change in weight. All analyses were performed using intention to treat analyses with mixed effect modelling.</div></div><div><h3>Findings</h3><div>Ninety-one participants (intervention, n = 46; usual care n = 45) were recruited. At the end of study, participants in the intervention group were twice as likely compared to the usual care group to report a minimum 5 % weight loss (21 % intervention and 7.5 % usual care participants, odds ratio: 2.5, p = 0.266). Intervention group participants also reported a larger weight loss, with a mean difference of 1.26 kg (95 %CI -2.36 kg to −0.15 kg) between groups. These differences were more significant especially among those who were more engaged with PRIME.</div></div><div><h3>Conclusion</h3><div>The intervention showed greater weight loss than the usual care, but the proportion of individuals achieving clinically meaningful weight loss (≥5 %) was not significant. PRIME program can be an important and useful tool to improve risk factors among individuals with prediabetes especially in a low-resource setting. Further research is needed to determine the economic and long-term sustainability of such programs.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 272-282"},"PeriodicalIF":2.8,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the concept and definition of scope of practice in pharmacy: A scoping review 探索药学实践范围的概念和定义:范围综述。
IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-03 DOI: 10.1016/j.sapharm.2025.09.007
Mitchell Budden , Shalom I. Benrimoj , Francisco Martinez Mardones , Sarah Dineen-Griffin

Background

The term scope of practice (SOP) is gaining increasing traction within the pharmacy profession, reflecting its growing importance. Despite this, definitions and interpretations remain varied, as evidenced by the number of definitions and the variety of synonyms and adjectives used in the literature.

Objectives

(i) To examine the conceptual diversity in terminology used to describe SOP for the pharmacy profession across different jurisdictions; (ii) to propose a curated list of definitions and examples, along with recommended contexts for their application at local, national, and international levels.

Methods

A scoping review was conducted following JBI methodology and reported according to PRISMA-ScR guidelines. PubMed, Scopus, Web of Science, and Embase were searched to January 2025. Grey literature was explored using Google, the Overton database, and other methods. Titles and abstracts of identified records were screened, followed by full-text review against inclusion criteria. Definitions were systematically categorised to identify thematic patterns, overlaps, and distinctions, informing the development of a curated list of SOP definitions for pharmacy.

Results

Of 4,010 peer-reviewed records, 2,106 were screened after removing duplicates, with 31 publications meeting inclusion criteria. An additional 49 grey literature reports were included. A total of 172 definitions were compiled, capturing both phrasing and contextual application of SOP terminology. While no single universally accepted definition emerged, most aligned with three dominant conceptual themes.

Conclusions

The growing focus on pharmacy SOP highlights the need for a more unified and strategic framework. Consolidating definitions into a curated and accessible resource can improve clarity and consistency across educational, clinical, policy, and regulatory domains.
背景:术语实践范围(SOP)在药学专业中越来越受到关注,反映了其日益增长的重要性。尽管如此,定义和解释仍然各不相同,这可以从文学中定义的数量和同义词和形容词的多样性中得到证明。目的:(i)检查不同司法管辖区用于描述药学专业SOP的术语的概念多样性;(ii)提出一份定义和例子的精选清单,以及在地方、国家和国际层面应用这些定义和例子的推荐背景。方法:根据JBI方法进行范围审查,并根据PRISMA-ScR指南进行报告。PubMed, Scopus, Web of Science和Embase被检索到2025年1月。使用谷歌、Overton数据库和其他方法对灰色文献进行了探索。筛选已确定记录的标题和摘要,然后根据纳入标准对全文进行审查。定义被系统地分类,以确定主题模式、重叠和区别,为制定药理学SOP定义的策划清单提供信息。结果:在4010篇同行评议的文献中,剔除重复文献后筛选了2106篇,其中31篇符合纳入标准。另外纳入49份灰色文献报告。总共编制了172个定义,捕获了SOP术语的措辞和上下文应用。虽然没有一个被普遍接受的定义出现,但大多数定义与三个主要概念主题一致。结论:药房SOP越来越受到重视,需要一个更加统一和战略性的框架。将定义整合到一个管理的和可访问的资源中,可以提高跨教育、临床、政策和监管领域的清晰度和一致性。
{"title":"Exploring the concept and definition of scope of practice in pharmacy: A scoping review","authors":"Mitchell Budden ,&nbsp;Shalom I. Benrimoj ,&nbsp;Francisco Martinez Mardones ,&nbsp;Sarah Dineen-Griffin","doi":"10.1016/j.sapharm.2025.09.007","DOIUrl":"10.1016/j.sapharm.2025.09.007","url":null,"abstract":"<div><h3>Background</h3><div>The term <em>scope of practice</em> (SOP) is gaining increasing traction within the pharmacy profession, reflecting its growing importance. Despite this, definitions and interpretations remain varied, as evidenced by the number of definitions and the variety of synonyms and adjectives used in the literature.</div></div><div><h3>Objectives</h3><div>(i) To examine the conceptual diversity in terminology used to describe SOP for the pharmacy profession across different jurisdictions; (ii) to propose a curated list of definitions and examples, along with recommended contexts for their application at local, national, and international levels.</div></div><div><h3>Methods</h3><div>A scoping review was conducted following JBI methodology and reported according to PRISMA-ScR guidelines. PubMed, Scopus, Web of Science, and Embase were searched to January 2025. Grey literature was explored using Google, the Overton database, and other methods. Titles and abstracts of identified records were screened, followed by full-text review against inclusion criteria. Definitions were systematically categorised to identify thematic patterns, overlaps, and distinctions, informing the development of a curated list of SOP definitions for pharmacy.</div></div><div><h3>Results</h3><div>Of 4,010 peer-reviewed records, 2,106 were screened after removing duplicates, with 31 publications meeting inclusion criteria. An additional 49 grey literature reports were included. A total of 172 definitions were compiled, capturing both phrasing and contextual application of SOP terminology. While no single universally accepted definition emerged, most aligned with three dominant conceptual themes.</div></div><div><h3>Conclusions</h3><div>The growing focus on pharmacy SOP highlights the need for a more unified and strategic framework. Consolidating definitions into a curated and accessible resource can improve clarity and consistency across educational, clinical, policy, and regulatory domains.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 195-208"},"PeriodicalIF":2.8,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145233749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Collaborative pharmacist prescribing models in Australian hospitals: A scoping study 澳大利亚医院的协作药剂师处方模式:一项范围研究。
IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-09-27 DOI: 10.1016/j.sapharm.2025.09.006
Hana Amer , Sally Marotti , Imaina Widagdo , Sharon Goldsworthy , Jacinta Johnson , Lisa Kalisch Ellett

Background

Collaborative pharmacist prescribing models have been trialled and implemented in Australian hospitals and involve credentialed pharmacists working with doctors and patients to develop patient medicine plans and prescribe medicines.

Aim

This study aimed to identify pharmacist prescribing policies and procedures in Australian hospitals and provide a narrative summary of the models and associated training.

Method

A scoping study was conducted using an exploratory and descriptive approach to identify and map pharmacist prescribing models implemented in Australian hospitals, and their associated training. Hospital pharmacy directors in Australia were contacted through a hospital pharmacy professional organisation in November 2023 and were asked to provide their pharmacist prescribing policies and procedures. Details of the models and training programs were extracted and summarised, with similarities and differences narratively reported.

Results

Fifteen different collaborative pharmacist prescribing models were reported to be implemented across more than 35 hospitals. Fourteen models had a formal training program. The models varied in scope of practice, particularly relating to medicine initiation and the timing of prescribing. The training and maintenance of currency of practice differed between models. Only three models recognised credentialing from other hospitals.

Conclusion

The study reveals variation in scope of practice, training, and credentialing processes between pharmacist prescribing models, with limited recognition and transferability of prescribing skills across jurisdictions in Australia. Efforts to establish national accreditation standards for pharmacist prescriber education programs and the recent introduction of a national credentialing program, could pave the way for the standardisation of the models and training within Australian hospitals.
背景:协作药剂师处方模式已在澳大利亚医院试行和实施,涉及有资格的药剂师与医生和患者合作制定患者用药计划和开药。目的:本研究旨在确定澳大利亚医院的药剂师处方政策和程序,并提供模型和相关培训的叙述性总结。方法:采用探索性和描述性方法进行范围研究,以确定和绘制澳大利亚医院实施的药剂师处方模型及其相关培训。2023年11月,通过一家医院药房专业组织联系了澳大利亚的医院药房主任,并要求他们提供药剂师开处方的政策和程序。对模型和训练方案的细节进行了提取和总结,并叙述了异同。结果:据报道,在超过35家医院实施了15种不同的协作药剂师处方模式。14名模特接受了正式的培训。这些模式在实践范围上各不相同,特别是与药物起始和处方时间有关。不同的模型对实践货币的培训和维护是不同的。只有三个模型承认其他医院的证书。结论:该研究揭示了药剂师处方模式之间的实践范围、培训和资格认证过程的差异,以及澳大利亚各司法管辖区对处方技能的有限认可和可转移性。为药剂师开处方者教育项目建立国家认证标准的努力,以及最近引入的国家资格认证项目,可以为澳大利亚医院内模式和培训的标准化铺平道路。
{"title":"Collaborative pharmacist prescribing models in Australian hospitals: A scoping study","authors":"Hana Amer ,&nbsp;Sally Marotti ,&nbsp;Imaina Widagdo ,&nbsp;Sharon Goldsworthy ,&nbsp;Jacinta Johnson ,&nbsp;Lisa Kalisch Ellett","doi":"10.1016/j.sapharm.2025.09.006","DOIUrl":"10.1016/j.sapharm.2025.09.006","url":null,"abstract":"<div><h3>Background</h3><div>Collaborative pharmacist prescribing models have been trialled and implemented in Australian hospitals and involve credentialed pharmacists working with doctors and patients to develop patient medicine plans and prescribe medicines.</div></div><div><h3>Aim</h3><div>This study aimed to identify pharmacist prescribing policies and procedures in Australian hospitals and provide a narrative summary of the models and associated training.</div></div><div><h3>Method</h3><div>A scoping study was conducted using an exploratory and descriptive approach to identify and map pharmacist prescribing models implemented in Australian hospitals, and their associated training. Hospital pharmacy directors in Australia were contacted through a hospital pharmacy professional organisation in November 2023 and were asked to provide their pharmacist prescribing policies and procedures. Details of the models and training programs were extracted and summarised, with similarities and differences narratively reported.</div></div><div><h3>Results</h3><div>Fifteen different collaborative pharmacist prescribing models were reported to be implemented across more than 35 hospitals. Fourteen models had a formal training program. The models varied in scope of practice, particularly relating to medicine initiation and the timing of prescribing. The training and maintenance of currency of practice differed between models. Only three models recognised credentialing from other hospitals.</div></div><div><h3>Conclusion</h3><div>The study reveals variation in scope of practice, training, and credentialing processes between pharmacist prescribing models, with limited recognition and transferability of prescribing skills across jurisdictions in Australia. Efforts to establish national accreditation standards for pharmacist prescriber education programs and the recent introduction of a national credentialing program, could pave the way for the standardisation of the models and training within Australian hospitals.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 185-194"},"PeriodicalIF":2.8,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Belief Model Interventions in Pre-exposure Prophylaxis (PrEP): Untapped intervention in the pharmacy arena 健康信念模型干预暴露前预防(PrEP):未开发的干预在药房领域。
IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-09-25 DOI: 10.1016/j.sapharm.2025.09.005
Alina Cernasev , Holly Angell , Karen Derefinko , Santosh Kumar , Theodore Cory
The human immunodeficiency virus (HIV) epidemic continues to be a major public health crisis in the United States. Although pre-exposure prophylaxis (PrEP) has emerged as an effective tool to prevent HIV transmission, its uptake and adherence remain suboptimal, especially among high-risk populations. This article explores how the Health Belief Model (HBM) can serve as a guiding framework for pharmacists and other healthcare professionals to enhance PrEP delivery and patient engagement.
Recent literature highlights persistent barriers to PrEP use, including stigma, perceived risk, misinformation, and healthcare access challenges. The five core components of the HBM—perceived severity, perceived susceptibility, perceived benefits, perceived barriers, and cues to action—have been used to understand and design interventions across multiple health behaviors. Studies suggest these components are useful in explaining patient behavior and provider limitations around PrEP, particularly in marginalized communities. While few studies directly apply HBM to PrEP adherence, evidence from related fields supports its predictive power.
The HBM offers a promising lens through which pharmacy-based interventions can be developed to address patient beliefs, reduce stigma, and increase PrEP uptake and adherence. Pharmacists, given their accessibility and trusted role in the community, are uniquely positioned to lead these efforts. Incorporating culturally responsive, HBM-informed strategies in pharmacy practice can significantly improve health outcomes in populations most affected by HIV.
人类免疫缺陷病毒(HIV)的流行仍然是美国主要的公共卫生危机。虽然暴露前预防(PrEP)已成为预防艾滋病毒传播的有效工具,但其吸收和坚持性仍然不理想,特别是在高危人群中。本文探讨了健康信念模型(HBM)如何作为药剂师和其他医疗保健专业人员的指导框架,以加强PrEP的交付和患者的参与。最近的文献强调了PrEP使用的持续障碍,包括耻辱,感知风险,错误信息和医疗保健获取挑战。hbm的五个核心组成部分——感知严重性、感知易感性、感知益处、感知障碍和行动线索——已被用于理解和设计跨多种健康行为的干预措施。研究表明,这些成分有助于解释PrEP的患者行为和提供者限制,特别是在边缘化社区。虽然很少有研究直接将HBM应用于PrEP依从性,但相关领域的证据支持其预测能力。HBM提供了一个有希望的视角,通过它可以开发基于药物的干预措施,以解决患者的信念,减少耻辱感,并增加PrEP的吸收和依从性。鉴于药剂师在社区中的可及性和可信赖的作用,他们在领导这些努力方面处于独特的地位。在药房实践中纳入文化响应和hbm知情战略可以显著改善受艾滋病毒影响最严重人群的健康结果。
{"title":"Health Belief Model Interventions in Pre-exposure Prophylaxis (PrEP): Untapped intervention in the pharmacy arena","authors":"Alina Cernasev ,&nbsp;Holly Angell ,&nbsp;Karen Derefinko ,&nbsp;Santosh Kumar ,&nbsp;Theodore Cory","doi":"10.1016/j.sapharm.2025.09.005","DOIUrl":"10.1016/j.sapharm.2025.09.005","url":null,"abstract":"<div><div>The human immunodeficiency virus (HIV) epidemic continues to be a major public health crisis in the United States. Although pre-exposure prophylaxis (PrEP) has emerged as an effective tool to prevent HIV transmission, its uptake and adherence remain suboptimal, especially among high-risk populations. This article explores how the Health Belief Model (HBM) can serve as a guiding framework for pharmacists and other healthcare professionals to enhance PrEP delivery and patient engagement.</div><div>Recent literature highlights persistent barriers to PrEP use, including stigma, perceived risk, misinformation, and healthcare access challenges. The five core components of the HBM—perceived severity, perceived susceptibility, perceived benefits, perceived barriers, and cues to action—have been used to understand and design interventions across multiple health behaviors. Studies suggest these components are useful in explaining patient behavior and provider limitations around PrEP, particularly in marginalized communities. While few studies directly apply HBM to PrEP adherence, evidence from related fields supports its predictive power.</div><div>The HBM offers a promising lens through which pharmacy-based interventions can be developed to address patient beliefs, reduce stigma, and increase PrEP uptake and adherence. Pharmacists, given their accessibility and trusted role in the community, are uniquely positioned to lead these efforts. Incorporating culturally responsive, HBM-informed strategies in pharmacy practice can significantly improve health outcomes in populations most affected by HIV.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 1","pages":"Pages 171-177"},"PeriodicalIF":2.8,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From global standards to local realities: Understanding the Granada Statements in pharmacy practice research 从全球标准到当地现实:理解格拉纳达声明在药学实践研究。
IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-09-16 DOI: 10.1016/j.sapharm.2025.09.004
Gizem Gülpınar , Aysel Pehlivanlı , Zaheer-Ud-Din Babar

Introduction

The Granada Statements were developed to improve the quality and visibility of pharmacy practice research by encouraging consistency in reporting. However, little is known about how these guidelines are interpreted in low- and middle-income countries (LMICs), where professional roles and services may differ. Examining these perspectives can highlight both barriers and opportunities for wider uptake.

Aim

This study explored how clinical and social pharmacy researchers perceive the Granada Statements, focusing on the challenges, enablers, and strategies that could enhance their application in resource-limited contexts.

Method

A qualitative design was adopted, using focus group discussions with researchers in Türkiye. Data were thematically analyzed through collaborative coding and interpretation. Special attention was given to the Statements’ key areas, including terminology, journal selection, perceptions of relevance, and proposed improvements.

Results

Participants regarded the Statements as a useful framework for clarifying expectations, promoting consistency, and stimulating dialogue about research quality. Barriers included difficulties applying standardized terminology in evolving service contexts, challenges in translating technical terms, undervaluation of LMIC research, financial constraints in open access publishing, and discouraging peer review experiences. Suggested enablers included templates, illustrative examples, modular adoption, culturally sensitive glossaries, and training with editors. A global classification framework for benchmarking pharmacy practice was also proposed.

Conclusion

This study shows that the Granada Statements have the potential to act not only as reporting guidance but also as a framework for more intentional, theory-driven, and globally relevant pharmacy practice research. Flexibility, contextual sensitivity, and institutional support are key to achieving this vision.
格拉纳达声明的制定是为了通过鼓励报告的一致性来提高药学实践研究的质量和可见性。然而,对于低收入和中等收入国家(LMICs)如何解释这些指南,人们知之甚少,这些国家的专业角色和服务可能有所不同。检查这些观点可以突出更广泛采用的障碍和机会。目的:本研究探讨临床和社会药学研究人员如何看待格拉纳达声明,重点关注在资源有限的情况下可以加强其应用的挑战、推动因素和策略。方法:采用定性设计,与 rkiye研究人员进行焦点小组讨论。通过协作编码和解释对数据进行主题分析。特别注意了《声明》的关键领域,包括术语、期刊选择、对相关性的认识和建议的改进。结果:与会者认为《声明》是澄清期望、促进一致性和促进关于研究质量的对话的有用框架。障碍包括在不断发展的服务环境中应用标准化术语的困难、翻译技术术语的挑战、对低收入和中等收入国家研究的低估、开放获取出版的财政限制以及不鼓励同行评议经验。建议的支持因素包括模板、说明性示例、模块化采用、具有文化敏感性的词汇表和编辑培训。同时,提出了一个全球性的药学实践基准分类框架。结论:本研究表明,格拉纳达声明不仅可以作为报告指南,还可以作为更有针对性的、理论驱动的、全球相关的药学实践研究的框架。灵活性、环境敏感性和机构支持是实现这一愿景的关键。
{"title":"From global standards to local realities: Understanding the Granada Statements in pharmacy practice research","authors":"Gizem Gülpınar ,&nbsp;Aysel Pehlivanlı ,&nbsp;Zaheer-Ud-Din Babar","doi":"10.1016/j.sapharm.2025.09.004","DOIUrl":"10.1016/j.sapharm.2025.09.004","url":null,"abstract":"<div><h3>Introduction</h3><div>The Granada Statements were developed to improve the quality and visibility of pharmacy practice research by encouraging consistency in reporting. However, little is known about how these guidelines are interpreted in low- and middle-income countries (LMICs), where professional roles and services may differ. Examining these perspectives can highlight both barriers and opportunities for wider uptake.</div></div><div><h3>Aim</h3><div>This study explored how clinical and social pharmacy researchers perceive the Granada Statements, focusing on the challenges, enablers, and strategies that could enhance their application in resource-limited contexts.</div></div><div><h3>Method</h3><div>A qualitative design was adopted, using focus group discussions with researchers in Türkiye. Data were thematically analyzed through collaborative coding and interpretation. Special attention was given to the Statements’ key areas, including terminology, journal selection, perceptions of relevance, and proposed improvements.</div></div><div><h3>Results</h3><div>Participants regarded the Statements as a useful framework for clarifying expectations, promoting consistency, and stimulating dialogue about research quality. Barriers included difficulties applying standardized terminology in evolving service contexts, challenges in translating technical terms, undervaluation of LMIC research, financial constraints in open access publishing, and discouraging peer review experiences. Suggested enablers included templates, illustrative examples, modular adoption, culturally sensitive glossaries, and training with editors. A global classification framework for benchmarking pharmacy practice was also proposed.</div></div><div><h3>Conclusion</h3><div>This study shows that the Granada Statements have the potential to act not only as reporting guidance but also as a framework for more intentional, theory-driven, and globally relevant pharmacy practice research. Flexibility, contextual sensitivity, and institutional support are key to achieving this vision.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 1","pages":"Pages 162-170"},"PeriodicalIF":2.8,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Common ailment and non-prescription medication-related problems faced by people with intellectual disability: Findings from medication reviews provided by pharmacists 智力残疾者面临的常见疾病和非处方药相关问题;药剂师提供的药物审查结果。
IF 2.8 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-09-13 DOI: 10.1016/j.sapharm.2025.09.001
Chelsea Felkai , Jamie-Lee Carew , David Newby , Joyce Cooper , Hayley Croft

Background

Pharmacists in Australia play a significant role in managing non-prescription medicines and common ailments. The aims of this research were to describe the medication related issues people with intellectual disability face with their common ailments and non-prescription medications and document the recommendations made by pharmacists as part of the medication review process.

Method

A retrospective analysis of medication review reports from credentialed pharmacists performed for a person with intellectual disability between January 2020 and January 2024.

Results

A total of 80 reports were analysed with an average of 6.6 common ailments and 8.0 non-prescription medications per individual with ID. The credentialed pharmacists identified an average of 3.6 issues related to their common ailment or non-prescription medication.

Conclusion

People with intellectual disability have significant issues managing common ailments and non-prescription medicines, that could potentially be more appropriately managed in the primary care setting.
背景:澳大利亚的药剂师在管理非处方药和常见疾病方面发挥着重要作用。本研究的目的是描述智障患者在常见疾病和非处方药方面面临的药物相关问题,并记录药剂师在药物审查过程中提出的建议。方法:回顾性分析2020年1月至2024年1月间执业药师对1例智障患者的药物评价报告。结果:共分析了80份报告,平均每个ID患者6.6种常见疾病和8.0种非处方药。有资格的药剂师平均发现了3.6个与他们的常见病或非处方药有关的问题。结论:智障人士在处理常见病和非处方药方面存在重大问题,这些问题可能在初级保健机构得到更适当的管理。
{"title":"Common ailment and non-prescription medication-related problems faced by people with intellectual disability: Findings from medication reviews provided by pharmacists","authors":"Chelsea Felkai ,&nbsp;Jamie-Lee Carew ,&nbsp;David Newby ,&nbsp;Joyce Cooper ,&nbsp;Hayley Croft","doi":"10.1016/j.sapharm.2025.09.001","DOIUrl":"10.1016/j.sapharm.2025.09.001","url":null,"abstract":"<div><h3>Background</h3><div>Pharmacists in Australia play a significant role in managing non-prescription medicines and common ailments. The aims of this research were to describe the medication related issues people with intellectual disability face with their common ailments and non-prescription medications and document the recommendations made by pharmacists as part of the medication review process.</div></div><div><h3>Method</h3><div>A retrospective analysis of medication review reports from credentialed pharmacists performed for a person with intellectual disability between January 2020 and January 2024.</div></div><div><h3>Results</h3><div>A total of 80 reports were analysed with an average of 6.6 common ailments and 8.0 non-prescription medications per individual with ID. The credentialed pharmacists identified an average of 3.6 issues related to their common ailment or non-prescription medication.</div></div><div><h3>Conclusion</h3><div>People with intellectual disability have significant issues managing common ailments and non-prescription medicines, that could potentially be more appropriately managed in the primary care setting.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 1","pages":"Pages 128-134"},"PeriodicalIF":2.8,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Research in Social & Administrative Pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1